Intrexon prepares to price $125M IPO [Startup Roundup]

Have news for the Startup Roundup? Get in touch.

who’s getting funded?

GlycoPure, Inc., based in Cambridge, has raised $700,000 in equity, according to SEC filings. The biotech company is modifying an existing method for converting the chemical compound chitin into glucosamine, “which is used in products sold as building blocks for cartilage.”

PrintLess Plans, based in Baltimore, received $100,000 from TEDCO‘s Technology Commercialization Fund, said cofounder Jared Lyles by e-mail. The startup, one of the six graduates from this year’s AccelerateBaltimore class, makes lightweight, large-format, electronic displays for carrying blueprints to construction sites.

who’s making moves?

Biotech company Intrexon Corp., based in Germantown, is preparing to price its IPO this week. According to CityBizList, Intrexon “plans to raise $125 million by offering 8.3 million shares at a price range of $14.00 to $16.00.” Intrexon, which focuses its efforts toward synthetic biology, recently raised $85.6 million in funding.
Canton-based online food-delivery startup OrderUp added six new digital franchises on Aug. 1. As Technically Baltimore reported in January, OrderUp allows individual franchisees to own and operate online food-ordering websites in places cofounder Chris Jeffery calls “units”: geographic areas with around 100,000 people and between 200 and 400 restaurants. Right now, OrderUp operates in 25 markets.